Imazethapyr, a systemic herbicide, is frequently applied to crops like soybeans, corn, sunflowers, and peanuts to control grasses and broadleaf weeds.
It is a member of the imidazolinone chemical family and functions by preventing the acetolactate synthase (ALS) enzyme, which is necessary for the production of certain amino acids in plants.
Typically, imazethapyr is used as a pre-emergent or post-emergent herbicide, either by itself or in conjunction with other herbicides.
It spreads throughout the plant after being absorbed by the roots and foliage of the target weeds, ultimately killing it. Imazethapyr’s efficacy can be affected by a number of variables, including time, soil type, weather, and weed species.
Imazethapyr is regarded as safe for use in crops when used in accordance with label directions, but if misused or applied excessively, it can be hazardous to non-target plants and animals.
While applying imazethapyr or any other herbicide, it’s crucial to stick to the safety precautions and label directions.
Global imazethapyr market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
The first non-GM (genetically modified) herbicide-imazethapyr tolerant rice varieties in the nation have been created by the Indian Agricultural Research Institute (IARI).
These varieties can be directly seeded and use substantially less water and labour than traditional transplanting methods. To ensure there are no foreign genes in the new kinds, the new herbicide-tolerant types were created by mutation breeding rather than genetic manipulation.
This is so that herbicides like Imazethapyr, which kill a variety of weeds, can be applied directly thanks to the new varieties. Herbicides are not used directly in traditional rice farming because they cannot tell the difference between the rice plant and weeds.
At Wuda Industrial Park, the company has set up a number of environmentally safe and highly effective herbicide technical production facilities, primarily producing nicosulfuron and imazethapyr.
During the project’s first phase, 500 tonnes of nicosulfuron, 350 tonnes of intermediate sulfonamide, and 50 tonnes of imazapic are used annually.
During the project’s second phase, 500 tonnes of imazethapyr, 200 tonnes of imazamox, 500 tonnes of nicosulfuron, and 350 tonnes of sulfonamide are used annually.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.